Increased disease burden in Interleukin-3 deficient mice after Mycobacterium tuberculosis and herpes simplex virus infections
S. Kunnath-Velayudhan, T. W. Ng, N. K. Saini, M. F. Goldberg, P. Arora, J. Xu, J. Kim, B. C. Herold, J. Chan, W. R. Jacobs, S. A. Porcelli
Abstract
Interleukin-3 (IL-3) is produced during infections caused by parasites, bacteria and viruses, but its contribution to immunity in this context remains largely unknown. In mouse models of parasitic infections, in which the effects of IL-3 have been most extensively studied, IL-3 has been variously reported as protective, detrimental or inconsequential. Similarly, mixed results have been reported in viral and bacterial infection models. Here, we investigated the effects of IL-3 in mouse models of Mycobacterium tuberculosis and herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) infections by assessing the pathogen burden, disease manifestations and survival following infection. After infection with M. tuberculosis, IL-3 deficient mice showed higher bacillary burden, increased lung pathology and reduced survival compared to wild type mice. After infection with HSV-1 through cutaneous route and HSV-2 through vaginal route, IL-3 deficient mice showed higher viral burden, increased disease manifestations and reduced survival compared to wild type mice. Our results show that IL-3 makes a subtle but significant contribution to protective immunity in these mouse models of bacterial and viral infections.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Interleukin-1 receptor antagonist mediates type I interferon-driven susceptibility to Mycobacterium tuberculosis
Daisy X. Ji, Katherine J. Chen, … Russell E. Vance·bioRxiv·Aug 10, 2018
- Tribbles1 and Cop1 cooperate to protect the host during in vivo mycobacterial infection
F. R. Hammond, A. Lewis, … P. M. Elks·bioRxiv·Aug 25, 2023
- IL-35 produced by dendritic cells via TIM-3-STAT3 signaling contributes to the development of visceral leishmaniasis
Sandeep Kumar, Shubham, … Pradip Sen·Cell Communication and SignalingPeer-reviewed·Sep 18, 2026
- Interleukin-1 receptor antagonist is a conserved factor for exacerbating tuberculosis susceptibility
O. V. Lee, E. Pathak, … D. I. Kotov·bioRxiv·Oct 27, 2023
- Mycobacterium tuberculosis stimulates IL-1β production by macrophages in an ESAT-6 dependent manner with the involvement of serum amyloid A3
B.-G. Jung, R. Vankayalapati, B. Samten·bioRxiv·Apr 4, 2020
- Early cellular mechanism of type I interferon-driven susceptibility to tuberculosis
D. I. Kotov, O. V. Lee, … R. E. Vance·bioRxiv·Oct 6, 2022